Vol 2023, No 5 (2023)

Table of Contents

Research & Development

Bayer Signs US$1.7 B Deal with Bicycle Therapeutics for Cancer Radiopharmaceuticals Abstract pdf html
Amit Kaushik

Licensing

Pipeline Therapeutics Signs Licensing Agreement with Janssen for Investigational Neurotherapeutic, PIPE-307 Abstract pdf html
Shweta Gupta
Janssen Signs Collaboration and License Agreement with Cellular Biomedicine to Develop CAR-T Therapies Abstract pdf html
Lalit Mishra
Lilly’s Prevail Signs Gene Editing Collaboration with Scribe Therapeutics for Neurological Diseases Abstract pdf html
Lucy Haggerty

Mergers & Acquisitions

Astellas Pharma to Acquire Iveric Bio for US$5.9 B Abstract pdf html
Ayush Saxena
Assertio to Acquire Spectrum Pharmaceuticals for Up to US$291 M Abstract pdf html
Ashish Tripathi
Ironwood to Acquire Rare Disease Specialist VectivBio for US$1 B Abstract pdf html
Lucy Haggerty


Creative Commons License
This work is licensed under a Creative Commons Attribution 3.0 License.